← Evidence map

ReviewClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2022

The contributing factors of resistance or sensitivity to epigenetic drugs in the treatment of AML.

Shohre Karimi Kelaye et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35076883